Trial intelligence / Profile preview

Jintropin AQ in Prader-Willi Syndrome

NCT03554031Phase 3Unknown

Sponsor
Changchun GeneScience Pharmaceutical Co., Ltd.
Start
Apr 2018
Primary completion
Jan 2020
Modality
Hormone, rProtein (Recombinant Protein), Biologic
Countries
1
01

Overview

A Phase 3 trial of somatropin in Prader-Willi syndrome (PWS), sponsored by Changchun GeneScience Pharmaceutical Co., Ltd.. Status: unknown.

02

Drugs

somatropin
03

Conditions

Prader-Willi syndrome (PWS)

Beyond the preview

Go deeper on NCT03554031.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03554031.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call